May
07, 2019: Global Bi-Specific Antibodies Market
is estimated to grow at a substantial CAGR in the forecast period as the scope,
product types, and its applications are increasing across the globe. The
bi-specific antibodies imply the next generation of targeted biologics formed
by engaging two dissimilar targets. These drugs offer a variety of benefits
over conventional treatment options for several diseases such as cancer.
The factors that propel
the growth of the Bi-Specific Antibodies Market include rise in the global
cancer epidemics, and growing demand for bi-specific/double barreled antibodies
and t-cells in bi-specific antibodies mediated immunotherapy. On the other hand,
there are factors that may hamper the growth of the market including regulatory
trials, and production hurdles in bi-specific antibodies growth.
Download
sample Copy of This Report at: https://www.radiantinsights.com/research/global-bi-specific-antibodies-market-forecast-to-2022/request-sample
Bi-Specific Antibodies
Market may be explored by key therapeutic areas, mechanisms of action, and
geography. Bi-Specific Antibodies Market may be explored by key therapeutic
areas as autoimmune disorders, oncology, eye disorders, inflammatory disorders,
and others. Bi-Specific Antibodies Market could be explored based on mechanisms
of action as NK-cell engagement, T-cell engagement, blocking cytokines, dual
targeting, and others.
Bi-Specific Antibodies
Market is categorized based on geography into North America, Latin America,
Japan, Middle East and Africa, Western Europe, Asia Pacific, and Eastern
Europe. North America and Europe accounted for the major share of the
Bi-Specific Antibodies Market Size in 2016 and will continue to lead in the
forecast period. The factors that could be attributed to the growth include
increasing occurrence of diseases such as lung cancer, prostate cancer, breast
cancer, and cervical cancer, and rise in the awareness levels toward health.
Browse
Full Report With TOC @ https://www.radiantinsights.com/research/global-bi-specific-antibodies-market-forecast-to-2022
The key players
contributing to the robust growth of the Bi-Specific Antibodies Market comprise
Bayer AG, Amgen, Inc., ImmunGene, Inc., Dow Pharmaceutical Solutions, Merck
& Co., Inc., Immunocore Limited, Novartis AG, F. Hoffmann-La Roche AG, and
Pfizer, Inc. The leading companies are taking up partnerships, mergers and
acquisitions, and joint ventures in order to boost the inorganic growth of the
industry.
Bi-specific antibody is
one of the most potentially powerful tools which have emerged in the
biopharmaceutical industry. The bi-specific antibodies intend to provide the
next generation of targeted biologics by engaging two different targets simultaneously.
These drugs offer several advantages over traditional treatment options for
various diseases such as cancer. They have fewer side effects due to high
specificity towards disease target. These antibodies are of particular
importance for patients who experience recurrence or resistance to drugs.
According to the RNCOS
report entitled “Global Bi-Specific Antibodies Market Forecast to 2022”, the
Global Bi-Specific Antibodies Market is anticipated to witness a double digit
growth during the forecast period. The report provides information about the
current and future scenario of this market. The report also highlights the
major drivers, such as increasing incidences of diseases and increasing demand
for effective treatment, for the Global Bi-Specific Antibodies Market.
Furthermore, the report also gives information related to the commercially
available bi-specific antibody drugs.
Moreover, few hindrances,
such as production hurdles and regulatory challenges, which are slowing down
the growth of the Global Bi-Specific Antibodies Market, have also been
mentioned in the report. In addition, the report also highlights various trends
and developments taking place in this market.
Furthermore, in this
report, we have structured the information regarding bi-specific antibodies at
various stages of clinical development. The pipeline chapter provides in depth
analysis of bi-specific antibodies by clinical phase, indications for which
they are being developed, and technology. Additionally, the study provides
all-inclusive current analysis of various bi-specific antibodies in advanced as
well as early stages of development. Moreover, our report places emphasis on
the strategic collaborations that can impact industry’s growth.
The prominent players in
Global Bi-Specific Antibodies Market have been discussed in the last section of
the report. A brief business overview and financial information about each of
these players has been provided, along with their product portfolios, product
pipeline and recent developments. Overall, the research contains exhaustive
information that will help clients in formulating market strategies and
assessing opportunity areas in the Global Bi-Specific Antibodies Market.
About
Radiant Insights
Radiant Insights is a
platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://pharmaceuticalshealthcaremarketforecasts.wordpress.com
No comments:
Post a Comment